KDNY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 16.79%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Chinook Therapeutics Insider Trading History Chart

Chinook Therapeutics Share Price & Price History

^$40.39

+0.30 (1.20%)

As of 08/11/2023 01:00 AM ET

Chinook Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/1/2023	Andrew James King	Insider	Sell	1,168	$39.03	$45,587.04	19,157
5/30/2023	William Mariner Greenman	Director	Sell	1,155	$23.30	$26,911.50	23,643
4/24/2023	Eric Dobmeier	CEO	Sell	23,800	$21.58	$513,604.00	302,338
4/17/2023	Jerel Davis	Director	Sell	295,808	$20.75	$6,138,016.00	443,713
4/4/2023	Mahesh Krishnan	Director	Sell	924	$23.01	$21,261.24	1,275
4/3/2023	Andrew James King	Insider	Sell	5,000	$23.34	$116,700.00	16,992
3/1/2023	Jerel Davis	Director	Sell	400,000	$22.75	$9,100,000.00	210,996
2/10/2023	Andrew James King	Insider	Sell	2,392	$23.75	$56,810.00	19,492
2/10/2023	Eric Bjerkholt	CFO	Sell	857	$23.75	$20,353.75	38,867
2/10/2023	Eric Dobmeier	CEO	Sell	8,097	$23.75	$192,303.75	301,138
2/10/2023	Tom Frohlich	COO	Sell	3,700	$23.75	$87,875.00	150,777
1/31/2023	Andrew James King	Insider	Sell	3,244	$24.68	$80,061.92	15,081
1/31/2023	Eric Bjerkholt	CFO	Sell	2,891	$24.68	$71,349.88	37,289
1/31/2023	Tom Frohlich	COO	Sell	4,566	$24.68	$112,688.88	147,674
1/30/2023	Eric Dobmeier	CEO	Sell	25,000	$24.54	$613,500.00	271,676
1/3/2023	Andrew James King	Insider	Sell	10,000	$25.82	$258,200.00	9,992
12/13/2022	Tom Frohlich	COO	Sell	10,000	$25.00	$250,000.00	143,907

SEC Filings (Institutional Ownership Changes) for Chinook Therapeutics (NASDAQ:KDNY)

95.15% of Chinook Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Chinook Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/21/2023	Barclays PLC	109,656	$4.21M	0.0%	+30.7%	0.153%
8/24/2023	Alberta Investment Management Corp	30,000	$1.15M	0.0%	N/A	0.042%
8/21/2023	Affinity Asset Advisors LLC	321,017	$12.33M	4.3%	-67.1%	0.447%
8/15/2023	Suvretta Capital Management LLC	1,748,141	$67.16M	3.6%	+11.4%	2.434%
8/15/2023	HighVista Strategies LLC	76,021	$2.92M	1.3%	+53.6%	0.106%
8/15/2023	Hudson Bay Capital Management LP	574,274	$22.06M	0.2%	+832.1%	0.800%
8/15/2023	Journey Strategic Wealth LLC	22,257	$0.86M	0.0%	N/A	0.031%
8/15/2023	Black Maple Capital Management LP	8,000	$0.31M	0.2%	N/A	0.011%
8/14/2023	EHP Funds Inc.	70,000	$2.69M	0.7%	N/A	0.097%
8/14/2023	Rock Springs Capital Management LP	396,280	$15.23M	0.4%	-21.9%	0.552%
8/14/2023	Driehaus Capital Management LLC	107,053	$4.11M	0.1%	-85.8%	0.149%
8/14/2023	Hunting Hill Global Capital LLC	7,433	$0.29M	0.1%	N/A	0.010%
8/14/2023	Prelude Capital Management LLC	66,445	$2.55M	0.2%	N/A	0.093%
8/11/2023	Natixis	1,352	$52K	0.0%	N/A	0.002%
8/11/2023	Sand Grove Capital Management LLP	315,973	$12.14M	1.4%	N/A	0.440%
8/11/2023	Hsbc Holdings PLC	442,815	$17.06M	0.0%	N/A	0.617%
8/11/2023	Franklin Resources Inc.	1,294,656	$49.74M	0.0%	-1.3%	1.803%
8/11/2023	JBF Capital Inc.	11,500	$0.44M	0.1%	N/A	0.016%
8/11/2023	E Fund Management Co. Ltd.	11,196	$0.43M	0.0%	+8.8%	0.016%
8/11/2023	PenderFund Capital Management Ltd.	16,480	$0.84M	0.3%	N/A	0.023%
8/10/2023	MetLife Investment Management LLC	30,585	$1.18M	0.0%	+15.4%	0.046%
8/10/2023	Metropolitan Life Insurance Co NY	3,169	$0.12M	0.0%	+15.5%	0.005%
8/10/2023	ProShare Advisors LLC	20,973	$0.81M	0.0%	+99.1%	0.031%
8/10/2023	Profund Advisors LLC	38,127	$1.47M	0.1%	+12.4%	0.057%
8/10/2023	Gamco Investors INC. ET AL	35,650	$1.37M	0.0%	N/A	0.053%
8/10/2023	Gabelli Funds LLC	154,861	$5.95M	0.0%	N/A	0.231%
8/10/2023	GABELLI & Co INVESTMENT ADVISERS INC.	128,600	$4.94M	0.8%	N/A	0.192%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	34,677	$1.33M	0.0%	+10.8%	0.052%
8/10/2023	KRYGER CAPITAL Ltd	244,657	$9.40M	1.0%	N/A	0.365%
8/10/2023	Alpine Associates Management Inc.	2,131,000	$81.87M	3.7%	N/A	3.178%
8/10/2023	Nicholas Investment Partners LP	928,637	$35.68M	2.4%	-4.5%	1.385%
8/10/2023	Charles Schwab Investment Management Inc.	375,239	$14.42M	0.0%	-0.8%	0.560%
8/10/2023	Mint Tower Capital Management B.V.	9,734	$0.37M	0.0%	N/A	0.015%
8/10/2023	Tekla Capital Management LLC	150,863	$5.80M	0.2%	+80.7%	0.225%
8/10/2023	Citigroup Inc.	104,573	$4.02M	0.0%	-29.3%	0.156%
8/9/2023	Dimensional Fund Advisors LP	1,336,934	$51.37M	0.0%	+4.1%	1.994%
8/9/2023	Swiss National Bank	100,300	$3.85M	0.0%	+11.8%	0.150%
8/8/2023	Fisher Asset Management LLC	22,820	$0.88M	0.0%	-36.4%	0.034%
8/8/2023	Rhumbline Advisers	89,242	$3.43M	0.0%	+9.1%	0.133%
8/8/2023	Candriam S.C.A.	826,155	$31.74M	0.2%	-10.8%	1.232%
8/7/2023	Principal Financial Group Inc.	24,599	$0.95M	0.0%	+1.5%	0.037%
8/7/2023	Wolverine Asset Management LLC	39,326	$1.51M	0.0%	N/A	0.059%
8/7/2023	Versor Investments LP	348,543	$13.39M	2.3%	N/A	0.520%
8/4/2023	American International Group Inc.	27,923	$1.07M	0.0%	+14.1%	0.042%
8/3/2023	Barclays PLC	109,656	$4.21M	0.0%	+30.7%	0.164%
8/3/2023	Fifth Lane Capital LP	10,000	$0.38M	0.1%	N/A	0.015%
8/3/2023	CWM LLC	3,190	$0.12M	0.0%	+170.3%	0.005%
8/3/2023	Bank of New York Mellon Corp	217,625	$8.36M	0.0%	+11.4%	0.325%
8/3/2023	Picton Mahoney Asset Management	125,000	$4.80M	0.2%	N/A	0.187%
8/2/2023	Values First Advisors Inc.	5,609	$0.22M	0.1%	+134.7%	0.008%
8/2/2023	Segantii Capital Management Ltd	400,000	$15.37M	0.8%	N/A	0.598%
8/1/2023	Arizona State Retirement System	12,946	$0.50M	0.0%	+7.5%	0.019%
7/31/2023	Strs Ohio	7,600	$0.29M	0.0%	-45.3%	0.011%
7/28/2023	Baillie Gifford & Co.	463,945	$17.83M	0.0%	-4.7%	0.694%
7/27/2023	Virtu Financial LLC	25,428	$0.98M	0.1%	N/A	0.038%
7/27/2023	GAM Holding AG	7,300	$0.28M	0.0%	N/A	0.011%
7/25/2023	Raymond James & Associates	15,281	$0.59M	0.0%	+10.1%	0.023%
7/25/2023	Olympiad Research LP	38,931	$1.50M	1.5%	N/A	0.058%
7/20/2023	Harvest Management LLC	60,000	$2.31M	2.0%	N/A	0.090%
7/19/2023	Teacher Retirement System of Texas	12,491	$0.48M	0.0%	-2.4%	0.019%
7/10/2023	SG Americas Securities LLC	59,342	$2.28M	0.0%	-61.4%	0.089%
5/22/2023	Putnam Investments LLC	180,343	$4.18M	0.0%	-1.6%	0.270%
5/18/2023	International Biotechnology Trust PLC	319,989	$7.41M	2.1%	-6.0%	0.478%
5/16/2023	Altium Capital Management LP	305,000	$7.06M	3.9%	-20.8%	0.456%
5/16/2023	Baker BROS. Advisors LP	1,455,202	$33.69M	0.2%	-42.6%	2.178%
5/15/2023	Affinity Asset Advisors LLC	976,021	$22.60M	7.5%	+19.3%	1.461%
5/15/2023	Suvretta Capital Management LLC	1,568,797	$36.32M	1.5%	+8.6%	2.348%
5/15/2023	EcoR1 Capital LLC	445,550	$10.31M	0.3%	-35.4%	0.667%
5/12/2023	C M Bidwell & Associates Ltd.	1,490	$34K	0.0%	-86.0%	0.002%
5/12/2023	Nicholas Investment Partners LP	972,191	$22.51M	1.7%	+51.3%	1.455%
5/12/2023	Profund Advisors LLC	33,924	$0.79M	0.0%	N/A	0.051%
5/11/2023	CHI Advisors LLC	135,000	$3.13M	0.8%	N/A	0.202%
5/11/2023	Citigroup Inc.	147,810	$3.42M	0.0%	+89.0%	0.221%
5/11/2023	E Fund Management Co. Ltd.	10,289	$0.24M	0.0%	+12.9%	0.015%
5/10/2023	Simplify Asset Management Inc.	25,000	$0.58M	0.1%	N/A	0.037%
5/10/2023	Pictet Asset Management SA	1,174,756	$27.20M	0.0%	+0.7%	1.758%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	170,211	$3.94M	0.0%	-27.8%	0.255%
5/10/2023	Tekla Capital Management LLC	83,500	$1.93M	0.1%	N/A	0.125%
5/9/2023	Tower Research Capital LLC TRC	5,029	$0.12M	0.0%	+389.2%	0.008%
5/9/2023	Integral Health Asset Management LLC	152,000	$3.52M	0.7%	-13.1%	0.227%
5/9/2023	Russell Investments Group Ltd.	18,692	$0.43M	0.0%	+21.4%	0.028%
5/8/2023	Federated Hermes Inc.	1,252,388	$28.99M	0.1%	+41.0%	1.874%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	5,841	$0.14M	0.0%	-7.7%	0.009%
5/4/2023	Barclays PLC	83,925	$1.94M	0.0%	-17.7%	0.127%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	31,285	$0.72M	0.0%	+28.1%	0.048%
5/3/2023	Baillie Gifford & Co.	486,595	$11.27M	0.0%	-0.6%	0.739%
5/2/2023	Victory Capital Management Inc.	991,014	$22.94M	0.0%	-14.8%	1.505%
5/2/2023	Amalgamated Bank	5,272	$0.12M	0.0%	-20.1%	0.008%
5/1/2023	Fisher Asset Management LLC	35,903	$0.83M	0.0%	-18.4%	0.055%
4/28/2023	SG Americas Securities LLC	153,882	$3.56M	0.0%	+1,818.5%	0.234%
4/27/2023	Arizona State Retirement System	12,042	$0.28M	0.0%	+4.4%	0.018%
4/26/2023	NJ State Employees Deferred Compensation Plan	13,000	$0.30M	0.0%	N/A	0.020%
4/20/2023	Hennion & Walsh Asset Management Inc.	36,946	$0.86M	0.1%	+40.1%	0.056%
4/18/2023	Assenagon Asset Management S.A.	1,371,469	$31.75M	0.1%	+54.4%	2.083%
4/13/2023	Allspring Global Investments Holdings LLC	4,474	$0.10M	0.0%	+38.1%	0.007%
3/10/2023	Victory Capital Management Inc.	1,163,245	$30.48M	0.0%	+13.3%	1.767%
2/16/2023	HealthCor Management L.P.	60,000	$1.57M	1.4%	-77.5%	0.094%
2/14/2023	Pura Vida Investments LLC	90,000	$2.36M	0.1%	N/A	0.141%
2/14/2023	Driehaus Capital Management LLC	772,700	$20.25M	0.3%	-12.4%	1.208%
2/13/2023	Gyon Technologies Capital Management LP	18,931	$0.50M	0.2%	N/A	0.030%

Data available starting January 2016

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington. As of August 11, 2023, Chinook Therapeutics, Inc. operates as a subsidiary of Novartis AG.

Today's Range

Now: $40.39

$40.39

50 Day Range

MA: $39.86

$38.66

$40.39

52 Week Range

Now: $40.39

$18.34

$40.51

Volume

N/A

Average Volume

1,186,257 shs

Market Capitalization

$2.90 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.34